Search

everythinglearnresearchcommunity

for

Search:↓

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Finasteride effectively reduces excess hair in women with certain conditions.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

Growth hormone therapy boosts androgen effects on skin in men.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Transgender patients use hair restoration surgery to match their hairline with their gender identity.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

A man developed hair loss from testosterone treatment but improved with additional medication.

A woman's virilization symptoms were caused by her partner's use of testosterone cream, which resolved after they separated.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

New compounds may soon be tested to treat excessive hair growth in women.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.